Recombinant Human EPO-R (C-6His)

Description

EnkiLife provides the Recombinant Human EPO-R (C-6His) protein,aslo know as EpoR,EPO-R,Erythropoietin R,erythropoietin receptor,MGC138358, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Erythropoietin Receptor is produced by our Mammalian expression system and the target gene encoding Ala25-Pro250 is expressed with a 6His tag at the C-terminus.Accession:P19235. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:25.9 KDa. Background:Erythropoietin (Epo), a glycoprotein produced primarily by the kidney, is the principal factor that regulates erythropoiesis by stimulating the proliferation and differentiation of erythroid progenitor cells. The biological effects of Epo are mediated by the erythropoietin receptor (Epo R). The presence of a soluble form of the Epo R has also been detected on human sera. Recombinant soluble Epo R binds Epo with high affinity and is a potent Epo antagonist.